Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis

Despite the use of various pharmacotherapeutic strategies, fibrosis due to nonalcoholic steatohepatitis (NASH) remains an unsatisfied clinical issue. We investigated the effect of sevelamer, a hydrophilic bile acid sequestrant, on hepatic fibrosis in a murine NASH model. Male C57BL/6J mice were fed...

Full description

Bibliographic Details
Main Authors:	Yuki Tsuji, Kosuke Kaji, Mitsuteru Kitade, Daisuke Kaya, Koh Kitagawa, Takahiro Ozutsumi, Yukihisa Fujinaga, Hiroaki Takaya, Hideto Kawaratani, Tadashi Namisaki, Kei Moriya, Takemi Akahane, Hitoshi Yoshiji
Format:	Article
Language:	English
Published:	MDPI AG 2020-06-01
Series:	Microorganisms
Subjects:	nonalcoholic steatohepatitis sevelamer lipopolysaccharide toll-like receptor 4
Online Access:	https://www.mdpi.com/2076-2607/8/6/925

Similar Items

Sevelamer-Induced Gastrointestinal Injury Presenting as Gastroenteritis
by: Jared Magee, et al.
Published: (2018-02-01)

Effect of sevelamer on serum phosphorus levels in chronic kidney disease and hemodialysis patients; a systematic review and meta-analysis
by: Farshad Gharebakhshi, et al.
Published: (2024-01-01)

Emerging Effects of Sevelamer in Chronic Kidney Disease
by: Ryota Ikee, et al.
Published: (2013-03-01)

The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial
by: Youssef Bennis, et al.
Published: (2019-05-01)

Phosphate binders in chronic kidney disease: The positions of sevelamer
by: V V Fomin, et al.
Published: (2013-06-01)

Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
by: Yu-Feng Lin, et al.
Published: (2010-09-01)

Sevelamer-associated ischemic colitis with perforation
by: Rachel Hudacko, et al.
Published: (2015-12-01)

Effect of Sevelamer on Mineral and Lipid Abnormalities in Hemodialysis Patients
by: Hamida Fethi, et al.
Published: (2008-01-01)

TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats
by: Daisuke Kaya, et al.
Published: (2019-09-01)

Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients
by: Qian Zeng, et al.
Published: (2023-12-01)

Colonic Mass Secondary to Sevelamer-associated Rectal Ulcer
by: Jin Hee Lee, et al.
Published: (2021-06-01)

Repurposing of sevelamer as a novel antidote against aluminum phosphide poisoning: An in vivo evaluation
by: Reza Heidari, et al.
Published: (2023-04-01)

Lanthanum carbonate for dialysis patients with hyperphosphataemia resistant to sevelamer: A retrospective cohort study
by: Asrar Khan, et al.
Published: (2016-12-01)

Sevelamer arsenite nanoparticle as a Pi-responsive drug carrier and embolic agent for chemoembolization
by: Qiu-Chen Bi, et al.
Published: (2022-12-01)

Uso del sevelamer en la enfermedad renal crónica. Más allá del control del fósforo
by: Laura Rodríguez-Osorio, et al.
Published: (2015-03-01)

Sevelamer Attenuates Bioprosthetic Heart Valve Calcification
by: Zhen Meng, et al.
Published: (2021-09-01)

Imeglimin Halts Liver Damage by Improving Mitochondrial Dysfunction in a Nondiabetic Male Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis
by: Kosuke Kaji, et al.
Published: (2024-11-01)

The Therapeutic Effects of Sevelamer on Blood Sugar, HbA1c, Lipid Profile, and hs-CRP in Patients with Diabetic Nephropathy
by: Sosan Mohammadi Kebar, et al.
Published: (2018-04-01)

Laser-cut-type versus braided-type covered self-expandable metallic stents for distal biliary obstruction caused by pancreatic carcinoma: a retrospective comparative cohort study
by: Koh Kitagawa, et al.
Published: (2022-05-01)

Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease—A Comparative Clinical Study
by: Parminder Nain, et al.
Published: (2023-02-01)

The Influence of Sevelamer Hydrochloride and Calcium Carbonate on Markers of Inflammation and Oxidative Stress in Hemodialysis at Six Months of Follow-Up
by: Elodia Nataly Díaz-De la Cruz, et al.
Published: (2021-11-01)

Evaluation of the safety and efficacy of transarterial sevelamer embolization in a rabbit liver cancer model: A challenge on the size rule for vascular occlusion
by: Hong Chen, et al.
Published: (2022-12-01)

Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients
by: Kosuke Kaji, et al.
Published: (2020-03-01)

Sevelamer hydrochloride and coronary artery calcification in chronic hemodialysis patients: a new mechanism of action
by: Bahaa Eldin Zayed, et al.
Published: (2015-01-01)

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat
by: Kawaratani Hideto, et al.
Published: (2009-05-01)

The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure
by: Hiroaki Takaya, et al.
Published: (2023-01-01)

Case report: Sevelamer-associated colitis—a cause of pseudotumor formation with colon perforation and life-threatening bleeding
by: Margareta Fistrek Prlic, et al.
Published: (2023-04-01)

Comparison of the efficacy and safety between palliative biliary stent placement and duct clearance among elderly patients with choledocholithiasis: a propensity score-matched analysis
by: Koh Kitagawa, et al.
Published: (2021-10-01)

Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug–Bug Interaction?
by: Lu Dai, et al.
Published: (2020-05-01)

Protein-Bound Uremic Toxins Lowering Effect of Sevelamer in Pre-Dialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized Controlled Trial
by: Kullaya Takkavatakarn, et al.
Published: (2021-09-01)

Efficacy of Underwater Endoscopic Mucosal Resection for Superficial Non-Ampullary Duodenal Epithelial Tumor
by: Masanori Furukawa, et al.
Published: (2021-05-01)

Hydralazine Sensitizes to the Antifibrotic Effect of 5-Aza-2′-deoxycytidine in Hepatic Stellate Cells
by: Kiyoshi Asada, et al.
Published: (2020-06-01)

Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
by: Shinya Sato, et al.
Published: (2019-03-01)

VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma
by: Hiroaki Takaya, et al.
Published: (2019-10-01)

The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects
by: Hirotetsu Takagi, et al.
Published: (2021-03-01)

Chemotherapy-associated steatohepatitis
by: Lucy Meunier, et al.
Published: (2020-11-01)

The effects of sevelamer carbonate on blood glucose and inflammatory factors in patients with diabetic kidney disease; a controlled clinical trial
by: Shadi Botshekan, et al.
Published: (2021-05-01)

Angiogenesis in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study)
by: Gavrilyuk O.M.
Published: (2013-12-01)

Acyclic retinoid and angiotensin-II receptor blocker exert a combined protective effect against diethylnitrosamine-induced hepatocarcinogenesis in diabetic OLETF rats
by: Norihisa Nishimura, et al.
Published: (2018-11-01)

Possible Amelioration of the Severity of Nutritional Steatohepatitis by Guggulsterone in Mice
by: Sara Ameen Nafeer, et al.
Published: (2019-06-01)